Phase 2Active, not recruiting
Stereotactic Radiotherapy Combined With Chemotherapy or Not for Treatment of Oligometastases in HNSCC (OMET)
Randomized Phase II Trial Comparing Chemotherapy Combined With Stereotactic Radiotherapy and Stereotactic Radiotherapy Alone, for Treatment of Oligometastases in Squamous Cell Cancers of the Upper Aerodigestive Tract
- Sponsor
- Groupe Oncologie Radiotherapie Tete et Cou (Academic or other)
- Enrolment
- 78 planned
- Conditions
- Head and Neck Squamous Cell Carcinoma
- Interventions
- Chemotherapy; Stereotactic radiotherapy
- Ages
- adults, older adults
- Registry
- NCT03070366
Full record on ClinicalTrials.gov
From the registry
The aim of this study is to evaluate the rate of living patients at 1 year with a quality of life criteria (no decrease) and reduced toxicities. This criteria will be compared in both groups., A cost effectiveness study is scheduled also.
Primary outcomes
- Overall Survival without quality of life deterioration
History
Primary completion expected
Last registry update
Registered
Started